NCT00483886View on ClinicalTrials.gov

Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation

PHASE3CompletedINTERVENTIONAL

Enrollment

620

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

May 31, 1999

Study Completion Date

May 31, 1999

Conditions

Constipation

Interventions

DRUG

Prucalopride

2 mg o.d.

OTHER

Placebo

Placebo o.d.

DRUG

Prucalopride

4 mg o.d.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Movetis

INDUSTRY